Skip to content

The efficacy evaluation of the knee subjective symptoms and motor function by collagen containing drink

The efficacy evaluation of the knee subjective symptoms and motor function by collagen containing drink - The efficacy evaluation of the knee subjective symptoms and motor function by collagen containing drink

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000027699
Enrollment
30
Registered
2017-06-09
Start date
2017-06-12
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Healthy adult

Interventions

Collagen containing drink are ingested for 12 consecutive weeks Collagen free drink are ingested for 12 consecutive weeks

Sponsors

TTC Co.,Ltd
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: (1)Males and females at the ages of 40 to 74 (2)Subjects who are judged as stage 1 in locomotive syndrome risk test (3)Subjects who confirmed pain of knee joint by JKOM and VAS (4)Subjects who are classified into 0-I grade on the basis of the Kellgren-Lawrence classification. (Subjects who undiagnosed with Knee Osteoarthritis by physician)

Exclusion criteria

Exclusion criteria: (1)Subjects who exceeded the value of knee pain on JKOM, question-I : the degree of pain, more than the sum VAS value of other joint pain (e.g., ankle, elbow, finger, shoulder, back and hip) (2)Subjects who are confirmed 30-points by JOA score, the degree of knee pain and walk ability (3)Subjects who are suspected gouty attack with hyperuricemia (4)Subjects who have positive rheumatoid factors on the screening test or may have rheumatic pain (5)Subjects who have performed arthroplasty or need it (6)Subjects who regularly take health food containing bone, joint, muscle wellness from three month before the screening test to the end of the study (7)Subjects who regularly take medicine (8)Subjects who have been performed intra-articular hyaluronic acid or steroid drug injection within a year before the screening test (9)Subjects who get an intense exercise to make excessive load on the joints (10)Subjects who have a history of the disorder related to bone and joint such as fracture and sprain within a year before the screening test (11)Subjects who regularly use a stick or supporter (12)Subjects who routinely exert an influence on the efficacy evaluation (13)Subjects who get a diagnosis of malignancy, are under treatment for hypertension, cardiac disease, renal disease and thyroid dysfunction, and have a history of serious disorder such as hepatic disease (14)Subjects who consume an excess amounts of alcohol (15)Subjects who have possibility of allergy symptoms onset by the test supplement (16)Subjects who are judged as unsuitable for the study based on the results of lifestyle questionnaire (17)Subjects who have participated in other clinical study within a month before the screening test or who intend to participate in study period (18)Subjects who intend to become pregnant or lactating (19)Subjects who are judged as unsuitable for this study by physician

Design outcomes

Primary

MeasureTime frame
locomotive syndrome risk test, JKOM before and 6, 12 weeks after the intervention with the test drink

Secondary

MeasureTime frame
JOA, levels of change in knee joint stiffness, VAS, handgrip before and 6, 12 weeks after the intervention with the test drink

Countries

Japan

Contacts

Public ContactNoriko Watanabe

TTC Co.,Ltd Clinical Research Planning Department

n.watanabe@ttc-tokyo.co.jp03-5459-5329

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026